Search results
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
GuruFocus.com via Yahoo Finance· 4 hours agoOn June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 20 hours agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19vaccine for the 2024-2025 fall season...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 1 day agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks via Yahoo Finance· 2 weeks agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 4 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks· 2 days agoFree Report) closed the most recent trading day at $14.06, moving +1.99% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.25% for the day. Heading ...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 2 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
Short Interest in Novavax, Inc. (NASDAQ:NVAX) Drops By 15.6%
ETF DAILY NEWS· 1 week agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) was the recipient of a significant decline in short interest during the month of May. As of May 31st, there was short interest ...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 1 week agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...